PNOC 017: A Target Validation /Phase1 Study of BGB-290 in Combination with Temozolomide in Adolescent and Young Adult IDH1/2 Newly Diagnosed and Recurrent Mutant Gliomas
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
The Regents of the University of California
Start Date
August 10, 2023
End Date
March 6, 2025
Administered By
Duke Cancer Institute
Awarded By
The Regents of the University of California
Start Date
August 10, 2023
End Date
March 6, 2025